Through a comprehensive evaluation of FIBG, PDGF-β, and TGF-β within the framework of the NNET diagnostic model, remarkable diagnostic efficacy was unveiled, surpassing that of traditional CRC biomarkers CEA and CA19-9 (Fig. 5B, C). Here, TGFB1 is linked to colorectal carcinoma.